Pretreatment SUV

Authors :: Paolo, Strati
Mohamed Amin, Ahmed
Loretta J, Nastoupil
Lei, Feng
Fredrick B, Hagemeister
Luis E, Fayad
Maria A, Rodriguez
Felipe, Samaniego
Michael, Wang
Jason R, Westin
Hun J, Lee
Swaminathan P, Iyer
Simrit, Parmar
Sairah, Ahmed
Ranjit, Nair
Raphael E, Steiner
Mansoor, Noorani
Christopher R, Flowers
R Eric, Davis
Nathan H, Fowler
Sattva S, Neelapu
Source :: Leukemialymphoma. 61(6)
Publication Year :: 2020
Abstract: In 2 randomized phase 3 trials BR resulted in longer progression-free survival (PFS) than frontline R-CHOP in patients with indolent and mantle cell lymphoma. However, in subset analyses of follicular lymphoma (FL), the results were incongruent. We conducted a retrospective matched-pair analysis to compare the outcome of patients with advanced stage FL, receiving frontline BR (

Subjects :: Adult
Doxorubicin
Vincristine
Antineoplastic Combined Chemotherapy Protocols
Humans
Prednisone
Prospective Studies
Rituximab
Cyclophosphamide
Lymphoma, Follicular
Retrospective Studies

Tools